Inflazyme Pharmaceuticals (T.IZP) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Steve Busse who wrote (16)	7/17/1996 8:27:00 PM
From: Sean Janzen	of 1501

Steve, Please update us on your meeting with Dr. Salari. Sorry, I didn't prepare any questions prior to your meeting. The institutional research paper by First Honolulu Securities, Inc. is very extensive and has kept me busy. Have you read the article? Any thoughts? In the latter part of the article it is stated "Cyclic AMP (cAMP) is of major importance in determining the positive effect of bronchodilators. The effect of Apanol on this pathway were examined in studies in sensitized animals and non-sensitized animals, yielding conflicting results. Phosphodiesterase studies were also inconclusive. Apanol did not affect activity of Protein kinase C, PL-3 kinase, or p561 tyrosine kinase. Nor did the studies confirm any effect upon the phosphodiesterase or cAMP pathways." What is the significance, if any, of this statement on the effectiveness of Apanol?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next